Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (611-620 of 897) with videos related to

Pageof 90
Sort By:
Bioinformatics (Oxford, England)|March 20, 2019
Differential network enrichment analysis reveals novel lipid pathways in chronic kidney diseaseJing Ma, Alla Karnovsky, Farsad Afshinnia, et al.
The Lancet. Diabetes & Endocrinology|May 31, 2015
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control studyDanish Saleheen, Robert Scott, Sundas Javad, et al.
Academic Radiology|February 25, 2015
A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomographyEmil M deGoma, Ali Salavati, Russell T Shinohara, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
Targeted Quantitative Plasma Metabolomics Identifies Metabolite Signatures that Distinguish Heart Failure with Reduced and Preserved Ejection FractionFawaz Naeem, Teresa C Leone, Christopher Petucci, et al.
Physiological Genomics|February 25, 2020
Circulating and tissue matricellular RNA and protein expression in calcific aortic valve diseaseAlexander P Kossar, Wanda Anselmo, Juan B Grau, et al.
Alzheimer'S Research & Therapy|December 26, 2022
ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer's diseaseYi-An Ko, Jeffrey T Billheimer, Nicholas N Lyssenko, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2008
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndromeJohn S Millar, Danielle Duffy, Ramprasad Gadi, et al.
Journal of the American College of Cardiology|February 21, 2012
Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosisJane F Ferguson, Christine C Hinkle, Nehal N Mehta, et al.
Autism : the International Journal of Research and Practice|February 5, 2026
Sleep and activity patterns in autismJ Dylan Weissenkampen, Arpita Ghorai, Thaise Nr Carneiro, et al.
Journal of Lipid Research|September 6, 2017
Polygenic determinants in extremes of high-density lipoprotein cholesterolJacqueline S Dron, Jian Wang, Cécile Low-Kam, et al.
Pageof 90

Showing results (611-620 of 897) with videos related to

Sort By:
Pageof 90
Bioinformatics (Oxford, England)|March 20, 2019
Differential network enrichment analysis reveals novel lipid pathways in chronic kidney diseaseJing Ma, Alla Karnovsky, Farsad Afshinnia, et al.
The Lancet. Diabetes & Endocrinology|May 31, 2015
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control studyDanish Saleheen, Robert Scott, Sundas Javad, et al.
Academic Radiology|February 25, 2015
A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomographyEmil M deGoma, Ali Salavati, Russell T Shinohara, et al.
Medrxiv : the Preprint Server for Health Sciences|August 7, 2024
Targeted Quantitative Plasma Metabolomics Identifies Metabolite Signatures that Distinguish Heart Failure with Reduced and Preserved Ejection FractionFawaz Naeem, Teresa C Leone, Christopher Petucci, et al.
Physiological Genomics|February 25, 2020
Circulating and tissue matricellular RNA and protein expression in calcific aortic valve diseaseAlexander P Kossar, Wanda Anselmo, Juan B Grau, et al.
Alzheimer'S Research & Therapy|December 26, 2022
ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer's diseaseYi-An Ko, Jeffrey T Billheimer, Nicholas N Lyssenko, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 8, 2008
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndromeJohn S Millar, Danielle Duffy, Ramprasad Gadi, et al.
Journal of the American College of Cardiology|February 21, 2012
Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosisJane F Ferguson, Christine C Hinkle, Nehal N Mehta, et al.
Autism : the International Journal of Research and Practice|February 5, 2026
Sleep and activity patterns in autismJ Dylan Weissenkampen, Arpita Ghorai, Thaise Nr Carneiro, et al.
Journal of Lipid Research|September 6, 2017
Polygenic determinants in extremes of high-density lipoprotein cholesterolJacqueline S Dron, Jian Wang, Cécile Low-Kam, et al.
Pageof 90